AU3138200A - (chlamydia) antigens and corresponding dna fragments and uses thereof - Google Patents

(chlamydia) antigens and corresponding dna fragments and uses thereof

Info

Publication number
AU3138200A
AU3138200A AU31382/00A AU3138200A AU3138200A AU 3138200 A AU3138200 A AU 3138200A AU 31382/00 A AU31382/00 A AU 31382/00A AU 3138200 A AU3138200 A AU 3138200A AU 3138200 A AU3138200 A AU 3138200A
Authority
AU
Australia
Prior art keywords
chlamydia
antigens
dna fragments
corresponding dna
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31382/00A
Inventor
Pamela Dunn
Andrew D. Murdin
Raymond P. Oomen
Joe Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Aventis Pasteur Ltd
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur Ltd, Aventis Pasteur SA filed Critical Aventis Pasteur Ltd
Publication of AU3138200A publication Critical patent/AU3138200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
AU31382/00A 1999-03-12 2000-03-09 (chlamydia) antigens and corresponding dna fragments and uses thereof Abandoned AU3138200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12396899P 1999-03-12 1999-03-12
US60123968 1999-03-12
PCT/CA2000/000239 WO2000053764A1 (en) 1999-03-12 2000-03-09 Chlamydia antigens and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
AU3138200A true AU3138200A (en) 2000-09-28

Family

ID=22412000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31382/00A Abandoned AU3138200A (en) 1999-03-12 2000-03-09 (chlamydia) antigens and corresponding dna fragments and uses thereof

Country Status (2)

Country Link
AU (1) AU3138200A (en)
WO (1) WO2000053764A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210876B1 (en) * 1996-06-06 2001-04-03 Abbott Laboratories Nucleic acid primers and probes for detecting Chlamydia pneumoniae
AU757762B2 (en) * 1997-08-28 2003-03-06 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College, The Vaccines for chlamydia psittaci infections

Also Published As

Publication number Publication date
WO2000053764A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AU7398200A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3760100A (en) Immunostimulatory nucleic acids and antigens
AU2001287430A1 (en) Moraxella polypeptides and corresponding dna fragments and uses thereof
AU8173098A (en) Neuroprotective methods and reagents
AU2138501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2001248172A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248171A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001248176A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU5245900A (en) Novel protein and dna thereof
AU2001248178A1 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
EP2088197B8 (en) Haemophilus influenzae antigens and corresponding DNA fragments
AU2001274566A1 (en) Novel protein and dna thereof
AU1891301A (en) Novel polypeptide and dna thereof
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2001285155A1 (en) Polymorphic dna fragments and uses thereof
AU1375501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2002216863A1 (en) Streptococcus pyogenes antigens and corresponding DNA fragments
AU7398400A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU5668500A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU3138200A (en) (chlamydia) antigens and corresponding dna fragments and uses thereof
AU7398700A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU1375601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU1375701A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU7398300A (en) Chlamydia antigens and corresponding dna fragments and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase